Novartis's Sandoz strikes deal for biosimilar of Herceptin

Novartis's Sandoz division has struck a deal with Taiwan's EirGenix Inc to market a biosimilar version of Roche's Herceptin that is now in late-stage development to treat some cancer tumors.


from Reuters: Health News https://reut.rs/2IUZsur
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Nevada Gov. Steve Sisolak Tests Positive For Coronavirus

Nevada Gov. Steve Sisolak Tests Positive For Coronavirus "With my case, I want to underscore the importance of Nevadans to stay at hom...